<DOC>
	<DOCNO>NCT00640042</DOCNO>
	<brief_summary>The purpose study provide information broad , `` real world '' population chronic pain patient assess pain control AVINZA well potential risk misuse abuse .</brief_summary>
	<brief_title>Evaluation Risk Minimization , Assessment Outcomes Patients With Chronic Pain Taking Avinza</brief_title>
	<detailed_description>Pain affect Americans diabetes , heart disease cancer combine although one early know ailment , pain still without universal cure . It estimate 25 % patient chronic pain receive adequate analgesia . Long-term treatment chronic pain opioids recognize important treatment option patient moderate-severe pain related cancer chronic serious illness . AVINZA ( morphine sulfate extended-release capsule ) approve market Food Drug Administration ( FDA ) 2002 daily treatment relief moderate severe pain require continuous opioid therapy extend period time . While opioids , AVINZA , beneficial management chronic pain , sometimes associate illicit activity . Misuse , abuse diversion control prescription drug , particularly opioids , problem increase dramatically United States ( U.S. ) since 1990s . This study follow Federation State Medical Boards Model Policy Use Controlled Substances Treatment Pain . Patients counsel proper storage destruction unused AVINZA accordance federal applicable state law . A universal precaution approach chronic pain management ( KAIR ) utilize study . Although validated risk assessment management instrument , KAIR design assist clinician responsibly manage chronic moderate-severe pain patient prescribe AVINZA . The KAIR tool use Investigator determine level monitoring require base patient 's potential risk opioid misuse abuse ( KAIR level ) . Investigators staff participate study require participate training program counseling give , procedure follow tool use study .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Patient adult ( great equal 21 year old Patient chronic ( great equal 3 month ) moderatesevere pain , discretion Investigator , require aroundtheclock opioid optimal analgesia . Patients may opioid naïve ( currently opioid ) opioid tolerant . Opioid naïve patient pain score great equal 4 11point NRS ( numerical rating scale . OR Opioid tolerant patient experience suboptimal response ( i.e . pain score great equal 4 ) unacceptable side effect sustain release opioids shortacting opioids . Patient able read understand English comply protocol requirement . A patient meet ANY follow exclusion criterion enrol : Hypersensitivity morphine , morphine salt , component AVINZA Respiratory depression ( slow breathing ) Acute severe bronchial asthma severe chronic obstructive pulmonary disease ( COPD ) Currently suspect paralytic ileus Requires daily dose AVINZA great 1600mg/day Patient abuse alcohol Pregnancy breast feed Currently take AVINZA Patient unwilling sign Treatment Agreement Life expectancy le 2 month Migraine primary pain score Patient reside hospital nursing home Patient 2 surgery low back pain Patient anticipate require major surgery steroid injection chronic pain next 12 week</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>pain</keyword>
	<keyword>opioid</keyword>
	<keyword>abuse</keyword>
	<keyword>moderate-severe pain require continuous , around-the-clock opioid therapy extend period time</keyword>
</DOC>